Peptide glossary · Reading the research

Double-blind

Checked against NCI Dictionary of Cancer Terms (National Cancer Institute)Published by PepVault

A double-blind trial is one in which neither the people taking part nor the researchers know who gets the treatment until the trial is over.

What it means

Keeping both sides blind makes the result less likely to be swayed by what people expect. The large GLP-1 trials in the library, such as tirzepatide’s SURMOUNT-1, were double-blind.

Why it matters when you track peptides

A double-blind result counts for more than a report from an open study, because expectation can change how people feel.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Put it to use in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Where you meet it

Checked against

NCI Dictionary of Cancer Terms (National Cancer Institute), “double-blind study”

Track it in the app

PepVault for iPhone

Put it to use in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo